Carmat S.A.
OTC: CKMTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Stephane Piat
- Employees
- 182
- Headquarters
- Vélizy-Villacoublay, France
- IPO year
- 2018
- Market cap
- $85.2M
- Website
- https://www.carmatsa.com
Loading CKMTF…
Loading profile data…Frequently asked questions about CKMTF
What does Carmat S.A. (CKMTF) do?
Carmat S.A. is dedicated to engineering and producing cutting-edge total artificial hearts. These innovative devices are developed to aid patients afflicted with severe, end-stage biventricular heart failure, serving markets in France and across the globe. The company was established in 2008 and operates from its primary base in Vélizy-Villacoub...
Where does CKMTF trade?
Carmat S.A. (CKMTF) trades on the Other OTC.
What sector is CKMTF in?
Carmat S.A. (CKMTF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Carmat S.A.?
Stephane Piat is the chief executive officer of Carmat S.A. (CKMTF).
Where is Carmat S.A. headquartered?
Carmat S.A. is headquartered in France.
Does CKMTF pay a dividend?
Carmat S.A. (CKMTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CKMTF go public?
Carmat S.A. (CKMTF) completed its initial public offering in 2018.